Compounds for treatment of angiogenesis-mediated diseases
Synthetic cremastranone and cremastranone analogs are disclosed. Additionally, methods for synthesizing cremastranone and cremastranone analogs are disclosed. Methods of treating ocular neovascularization disorders and treating angiogenesis-mediated disease are also disclosed.
1. A synthetic compound comprising formula (I)
wherein R 1 is selected from the group consisting of hydroxyl and alkoxy, R 2 is selected from the group consisting of hydroxyl, alkoxy, substituted alkoxy, alkyl carbonyloxy, substituted alkyl carbonyloxy, alkyl carbonyl, substituted alkyl carbonyl, aryl carbonyloxy, substituted aryl carbonyloxy, halogen, amino, nitro, hydrocarbyl and substituted hydrocarbyl; R 3 is selected from the group consisting of hydroxyl and alkoxy; R 4 is independently selected from the group consisting of hydroxyl, alkoxy, substituted alkoxy, alkyl carbonyloxy, substituted alkyl carbonyloxy, alkyl carbonyl, substituted alkyl carbonyl, aryl carbonyloxy, substituted aryl carbonyloxy, halogen, amino, nitro, hydrocarbyl and substituted hydrocarbyl; R 5 is independently selected from the group consisting of hydrogen, alkoxy, substituted alkoxy, alkyl carbonyloxy, substituted alkyl carbonyloxy, alkyl carbonyl, aryl carbonyloxy, substituted aryl carbonyloxy, halogen, amino, nitro, hydrocrabyl and substituted hydrocarbyl; X is selected from the group consisting of CH, nitrogen, and Y, and Z are independently selected from the group consisting of CH 2 , nitrogen, and oxygen, wherein when R 1 is hydroxyl and R 2 is an alkoxy, R 3 is not hydroxy.
2. The synthetic compound selected from the group consisting of
.